"Dyslipidemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Descriptor ID |
D050171
|
| MeSH Number(s) |
C18.452.584.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dyslipidemias".
Below are MeSH descriptors whose meaning is more specific than "Dyslipidemias".
This graph shows the total number of publications written about "Dyslipidemias" by people in this website by year, and whether "Dyslipidemias" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dyslipidemias" by people in Profiles.
-
Dyslipidemia in Human Immunodeficiency Virus Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 07 11; 82(2):171-181.
-
Management of diabetic dyslipidemia in South Asian patients: The need for individualized treatment guidelines. J Clin Lipidol. 2023 May-Jun; 17(3):313-314.
-
Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:2-6.
-
HDL-Targeted Therapies During Myocardial Infarction. Cardiovasc Drugs Ther. 2019 06; 33(3):371-381.
-
Risk factors for longitudinal changes in left ventricular diastolic function among women and men. Heart. 2019 09; 105(18):1414-1422.
-
The role of DNA methylation in dyslipidaemia: A systematic review. Prog Lipid Res. 2016 10; 64:178-191.
-
Lipoprotein(a) and Increased Cardiovascular Risk in Women. Clin Cardiol. 2016 Feb; 39(2):96-102.
-
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J Clin Lipidol. 2015 Nov-Dec; 9(6 Suppl):S1-122.e1.
-
Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Altern Ther Health Med. 2011 Mar-Apr; 17(2):30-5.
-
Aspirin resistance with genetic dyslipidemia: contribution of vascular thromboxane generation. Physiol Genomics. 2010 Aug; 42(3):331-41.